{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:41:30Z","timestamp":1793446890873,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T00:00:00Z","timestamp":1508457600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s15010-017-1077-1","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T06:29:57Z","timestamp":1508480997000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Suppressive antibiotic therapy with oral tetracyclines for prosthetic joint infections: a retrospective study of 78 patients"],"prefix":"10.1007","volume":"46","author":[{"given":"M.","family":"Pradier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Robineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Titecat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Blondiaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Valette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lo\u00efez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Beltrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"D\u00e9zeque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Migaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5720-8908","authenticated-orcid":false,"given":"Eric","family":"Senneville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,20]]},"reference":[{"key":"1077_CR1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1302\/0301-620X.95B11.33135","volume":"11","author":"J Parvizi","year":"2013","unstructured":"Parvizi J, Gehrke T, Chen AF. Proceedings of the international consensus on periprosthetic joint infection. Bone Joint J. 2013;11:1450\u20132.","journal-title":"Bone Joint J"},{"key":"1077_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/cid\/cis803","volume":"56","author":"DR Osmon","year":"2013","unstructured":"Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR. Infectious Diseases Society of America. Infectious Diseases Society of America. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:25. doi: 10.1093\/cid\/cis803 .","journal-title":"Clin Infect Dis"},{"key":"1077_CR3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00003088-198815060-00001","volume":"15","author":"S Saivin","year":"1988","unstructured":"Saivin S, Houin G. Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinet. 1988;15:355\u201366.","journal-title":"Clin Pharmacokinet"},{"key":"1077_CR4","first-page":"S54","volume":"1976","author":"H Gnarpe","year":"1976","unstructured":"Gnarpe H, Dornbusch K, Hagg O. Doxycycline concentration levels in bone, soft tissue and serum after intravenous infusion of doxycycline. Scand J Infect Dis. 1976;1976:S54\u20137.","journal-title":"Scand J Infect Dis"},{"key":"1077_CR5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","volume":"58","author":"KN Agwuh","year":"2006","unstructured":"Agwuh KN, MacGowan A. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother. 2006;58:256\u201365.","journal-title":"J Antimicrob Chemother"},{"key":"1077_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-1383(11)70126-7","author":"S Thompson","year":"2011","unstructured":"Thompson S, Townsend R. Pharmacological agents for soft tissue and bone infected with MRSA: which agent and for how long? Injury. 2011;. doi: 10.1016\/S0020-1383(11)70126-7 .","journal-title":"Injury"},{"key":"1077_CR7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00614205","volume":"30","author":"R Bocker","year":"1986","unstructured":"Bocker R, Muhlberg W, Platt D, Estler CJ. Serum level, half-life and apparent volume of distribution of doxycycline in geriatric patients. Eur J Clin Pharmacol. 1986;30:105\u20138.","journal-title":"Eur J Clin Pharmacol"},{"key":"1077_CR8","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMra040181","volume":"351","author":"W Zimmerli","year":"2004","unstructured":"Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645\u201354.","journal-title":"N Engl J Med"},{"key":"1077_CR9","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/jac\/dkp107","volume":"63","author":"I Byren","year":"2009","unstructured":"Byren I, Bejon P, Atkins BL, Angus B, Masters S, McLardy-Smith P, Gundle R, Berendt A. One hundred and twelve infected arthroplasties treated with \u2018DAIR\u2019 (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother. 2009;63:1264\u201371.","journal-title":"J Antimicrob Chemother"},{"key":"1077_CR10","doi-asserted-by":"crossref","first-page":"R168","DOI":"10.1186\/ar3491","volume":"13","author":"CJ Smith","year":"2011","unstructured":"Smith CJ, Sayles H, Mikuls TR, Michaud K. Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level de determinants of use, and patient-reported side effects. Arthritis Res Therapy. 2011;13:R168.","journal-title":"Arthritis Res Therapy."},{"key":"1077_CR11","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","volume":"27","author":"K Smith","year":"2005","unstructured":"Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review. Clin Ther. 2005;27:1329\u201342.","journal-title":"Clin Ther"},{"key":"1077_CR12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/514951","volume":"27","author":"J Segreti","year":"1998","unstructured":"Segreti J, Nelson JA, Trenholme GM. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis. 1998;27:711\u20133.","journal-title":"Clin Infect Dis"},{"key":"1077_CR13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.blo.0000087321.60612.cf","volume":"414","author":"N Rao","year":"2003","unstructured":"Rao N, Crossett LS, Sinha RK, Le Frock JL. Long-term suppression of infection in total joint arthroplasty. Clin Orthop Relat Res. 2003;414:55\u201360.","journal-title":"Clin Orthop Relat Res"},{"key":"1077_CR14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0883-5403(88)80075-5","volume":"3","author":"JA Goulet","year":"1988","unstructured":"Goulet JA, Pellicci PM, Brause BD, Salvati EM. Prolonged suppression of infection in total hip arthroplasty. J Arthroplast. 1988;3:109\u201316.","journal-title":"J Arthroplast"},{"key":"1077_CR15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3928\/0147-7447-19910801-07","volume":"14","author":"DT Tsukayama","year":"1991","unstructured":"Tsukayama DT, Wicklund B, Gustilo RB. Suppressive antibiotic therapy in chronic prosthetic joint infections. Orthopedics. 1991;14:841\u20134.","journal-title":"Orthopedics."},{"key":"1077_CR16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijid.2014.09.012","volume":"29","author":"V Prendki","year":"2014","unstructured":"Prendki V, Zeller V, Passeron D, Desplaces N, Mamoudy P, Stirnemann J, Marmor S, Ziza JM. Outcome of patients over 80\u00a0years of age on prolonged suppressive antibiotic therapy for at least 6\u00a0months for prosthetic joint infection. Int J Infect Dis. 2014;29:184\u20139.","journal-title":"Int J Infect Dis"},{"key":"1077_CR17","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2106\/JBJS.N.00999","volume":"97","author":"MB Siqueira","year":"2015","unstructured":"Siqueira MB, Saleh A, Klika AK, O\u2019Rourke C, Schmitt S, Higuera CA, Barsoum WK. Chronic suppression of periprosthetic joint infections with oral antibiotics increases infection-free survivorship. J Bone Joint Surg Am. 2015;97:1220\u201332.","journal-title":"J Bone Joint Surg Am"},{"key":"1077_CR18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/IPC.0b013e31816d2118","volume":"16","author":"J Koeppe","year":"2008","unstructured":"Koeppe J, Johnson S, Morroni J, Siracusa-Rick C, Armon C. Suppressive antibiotic therapy for retained infected prosthetic joints: case series and review of the literature. Infect Dis Clin Pract. 2008;16:224\u20139.","journal-title":"Infect Dis Clin Pract"},{"key":"1077_CR19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1469-0691.2007.01691.x","volume":"13","author":"CA Aboltins","year":"2007","unstructured":"Aboltins CA, Page MA, Buising KL, Jenney AW, Daffy JR, Choong PF, Stanley PA. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid. Clin Microbiol Infect. 2007;13:586\u201391.","journal-title":"Clin Microbiol Infect"},{"key":"1077_CR20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/cid\/cis746","volume":"56","author":"J Lora-Tamayo","year":"2013","unstructured":"Lora-Tamayo J, Murillo O, Iribarren JA, Soriano A, S\u00e1nchez-Somolinos M, Baraia-Etxaburu JM, Rico A, Palomino J, Rodr\u00edguez-Pardo D, Horcajada JP, Benito N, Bahamonde A, Granados A, del Toro MD, Cobo J, Riera M, Ramos A, Jover-S\u00e1enz A, Ariza J, REIPI Group for the Study of Prosthetic Infection. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention. Clin Infect Dis. 2013;56:182\u201394.","journal-title":"Clin Infect Dis"},{"key":"1077_CR21","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/j.1469-0691.2010.03333.x","volume":"17","author":"J Cobo","year":"2011","unstructured":"Cobo J, Garcia San Miguel L, Euba G, Rodr\u0131guez D, Garc\u0131a-Lechuz JM, Riera M, Falgueras L, Palomino J, Benito N, del Toro MD, Pigrau C, Ariza J. Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy. Clin Microbiol Infect. 2011;17:1632\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"1077_CR22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cid\/cir402","volume":"53","author":"E Senneville","year":"2011","unstructured":"Senneville E, Joulie D, Legout L, Valette M, Dez\u00e8que H, Beltrand E, Rosel\u00e9 B, d\u2019Escrivan T, Lo\u00efez C, Caillaux M, Yazdanpanah Y, Maynou C, Migaud H. Outcome and predictors of treatment failure in total hip\/knee prosthetic joint infections due to Staphylococcus aureus. Clin Infect Dis. 2011;53:334\u201340.","journal-title":"Clin Infect Dis"},{"key":"1077_CR23","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/529436","volume":"46","author":"BY Betsch","year":"2008","unstructured":"Betsch BY, Eggli S, Siebenrock KA, T\u00e4uber MG, M\u00fchlemann K. Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clin Infect Dis. 2008;46:1221\u20136.","journal-title":"Clin Infect Dis"},{"key":"1077_CR24","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/jama.1980.03310100021021","volume":"244","author":"NA Fenske","year":"1980","unstructured":"Fenske NA, Millns JL, Greer KE. Minocycline-induced pigmentation at sites of cutaneous inflammation. JAMA. 1980;244:1103\u20136.","journal-title":"JAMA"},{"key":"1077_CR25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2165\/00002018-200023040-00006","volume":"23","author":"RA Lawrenson","year":"2000","unstructured":"Lawrenson RA, Seaman HE, Sundstr\u00f6m A, Williams TJ, Farmer RD. Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmaco-vigilance data. Drug Saf. 2000;23:333\u201349.","journal-title":"Drug Saf"},{"key":"1077_CR26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.anai.2015.12.010","volume":"116","author":"J Lan","year":"2016","unstructured":"Lan J, Lahoti A, Lew DB. A severe case of minocycline-induced DRESS resulting in liver transplantation and autoimmune sequelae. Ann Allergy Asthma Immunol. 2016;116:367\u20138.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1077_CR27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/pds.1547","volume":"17","author":"SB Meropol","year":"2008","unstructured":"Meropol SB, Chan KA, Chen Z, Finkelstein JA, Hennessy S, Lautenbach E, Platt R, Schech SD, Shatin D, Metlay JP. Adverse events associated with prolonged antibiotic use. Pharmacoepidemiol Drug Saf. 2008;17:523\u201332.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1077_CR28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5152\/tjg.2014.5415","volume":"25","author":"MS Da\u011f","year":"2014","unstructured":"Da\u011f MS, \u00d6zt\u00fcrk ZA, Ak\u0131n I, Tutar E, \u00c7\u0131kman \u00d6, G\u00fcl\u015fen MT. Drug-induced\u00a0esophageal ulcers: case series and the\u00a0review\u00a0of the literature. Turk J Gastroenterol. 2014;25:180\u20134.","journal-title":"Turk J Gastroenterol."},{"key":"1077_CR29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/antibiotics4020216","volume":"4","author":"YP Hung","year":"2015","unstructured":"Hung YP, Lee JC, Lin HJ, Liu HC, Wu YH, Tsai PJ, Ko WC. Doxycycline and tigecycline: two friendly drugs with a low association with clostridium difficile infection. Antibiotics (Basel). 2015;4:216\u201322.","journal-title":"Antibiotics (Basel)."},{"key":"1077_CR30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/cid\/cis457","volume":"55","author":"SB Doernberg","year":"2012","unstructured":"Doernberg SB, Winston LG, Deck DH, Chambers HF. Does doxycycline protect against development of Clostridium difficile infection? Clin Infect Dis. 2012;55:615\u201320.","journal-title":"Clin Infect Dis"},{"key":"1077_CR31","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/1060028014528792","volume":"48","author":"RB Turner","year":"2014","unstructured":"Turner RB, Smith CB, Martello JL, Slain D. Role of doxycycline in Clostridium difficile infection acquisition. Ann Pharmacother. 2014;48:772\u20136.","journal-title":"Ann Pharmacother"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-017-1077-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-017-1077-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-017-1077-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T22:55:38Z","timestamp":1659653738000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-017-1077-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,20]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1077"],"URL":"https:\/\/doi.org\/10.1007\/s15010-017-1077-1","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,20]]}}}